SGLT2 Inhibitors and how they work beyond the glucosuric effect. State of the art

Type 2 diabetes mellitus (T2DM) is associated with a heightened risk of cardiovascular and renal complications. While glycemic control remains essential, newer therapeutic options, such as SGLT2 inhibitors, offer additional benefits beyond glucose reduction. This review delves into the mechanisms un...

Full description

Autores:: Aristizábal‑Colorado, David
Ocampo‑Posada, Martín
Rivera‑Martínez, Wilfredo Antonio
Corredor‑Rengifo, David
Rico‑Fontalvo, Jorge
Gómez‑Mesa, Juan Esteban
Duque‑Ossman, John Jairo
Abreu‑Lomba, Alin

Tipo de recurso:

Fecha de publicación:: 2024

Institución:: Universidad Simón Bolívar

Repositorio:: Repositorio Digital USB

Idioma:: eng